Satellite Symposia Resources from OncologyPRO sponsors
Find here all the resources from Industry Satellite Symposia published by our industry partners.
Treatment Sequencing in HER2-Positive Metastatic Breast Cancer: From Guidelines to Clinical Practice
- Introduction
- Patient case study: how does treatment sequencing vary in local clinical practice across Europe for HER2-positive MBC?
- Patient case study: how does local clinical practice vary for patients with brain metastases?
- Which local factors influence treatment sequencing for HER2-positive MBC?
- Consistency of approach: how can we personalise and adapt treatment sequencing for patients with HER2-positive MBC?
- Q&A
- Summary and session close
Broadening Horizons in HER2- Advanced Breast Cancer
- Welcome and introductions
- Expanding perspectives: Progress in treatment choice in HER2- aBC
- Managing individual needs: Real-world evidence in HER2- aBC
- Q&A, discussion and close
Aiming to Minimize the Risk of Recurrence in Early Breast Cancer: Integrating Risk Assessment and Adjuvant Therapies into Practice
- Welcome and Introduction
- Predicting Risk of Recurrence in HR-positive, HER2-negative Early Breast Cancer: A Focus on Clinicopathological Factors
- Tools to Guide Risk Assessment and Adjuvant Treatment Decisions in HR-positive, HER2-negative Early Breast Cancer: A Focus on Best Practices
- Impact of CDK4/6 Inhibitors as Adjuvant Therapy in HR-positive, HER2-negative Early Breast Cancer: A Focus on Recent Evidence
- Optimizing the Use of CDK4/6 Inhibitors as Adjuvant Therapy in HR-positive, HER2-negative Early Breast Cancer: A Focus on Patient Management
- Questions and Take-Home Learnings